Obstructive and restrictive lung disease, pulmonary embolism
What separates obstructive from restrictive disease, the pathology of asthma, chronic obstructive pulmonary disease and bronchiectasis, the restrictive and interstitial diseases, the pathology and consequences of pulmonary embolism, and the mechanisms of the acute respiratory distress syndrome.
By the end of this page you should be able to
- Distinguish obstructive from restrictive disease by mechanism, spirometry and flow-volume loop.
- Describe the pathology of asthma and explain the changes of chronic airway remodelling.
- Describe the pathology of chronic obstructive pulmonary disease, including emphysema and chronic bronchitis.
- Describe the causes and pathology of restrictive disease, both parenchymal and extrapulmonary.
- Describe the sources, pathology and haemodynamic consequences of pulmonary embolism.
- Explain the pathogenesis of the acute respiratory distress syndrome.
The two patterns
Obstructive disease limits airflow. The ratio of forced expiratory volume in one second to forced vital capacity is reduced, residual volume and total lung capacity are increased by gas trapping, and the flow-volume loop has a scooped, concave expiratory limb. The mechanism is narrowing, whether from smooth muscle contraction, mucosal oedema, secretions, or loss of the radial traction and elastic recoil that hold airways open.
Restrictive disease limits volume. Total lung capacity and vital capacity are reduced, the ratio is normal or raised, and the loop is narrow but keeps its shape. The cause may be parenchymal (fibrosis, oedema, consolidation, resection) or extrapulmonary (pleural disease, chest wall deformity, obesity, neuromuscular weakness, raised intra-abdominal pressure, pain and splinting), and the two are separated by the gas transfer factor, which falls in parenchymal disease and is preserved or raised in extrapulmonary restriction.
A fixed upper airway lesion flattens both limbs of the loop, while a variable extrathoracic lesion flattens the inspiratory limb and an intrathoracic one the expiratory limb; this is how a stridulous patient is characterised physiologically.
Asthma
- Pathology: a chronic inflammatory disease of the airways, in which inhaled allergen presented to T helper 2 lymphocytes drives IgE production, mast cell sensitisation and eosinophilic inflammation. Mediators (histamine, leukotrienes, prostaglandins, cytokines) cause smooth muscle contraction, mucosal oedema and mucus hypersecretion, the three reversible components of obstruction.
- Macroscopic and microscopic findings in fatal asthma: hyperinflated lungs, mucus plugging of airways, and microscopically goblet cell hyperplasia, thickening of the basement membrane, smooth muscle hypertrophy, eosinophilic infiltration, Curschmann spirals and Charcot-Leyden crystals.
- Remodelling with repeated inflammation produces a fixed component: basement membrane thickening, subepithelial fibrosis, muscle hypertrophy and angiogenesis, so reversibility declines over years.
- Physiological consequences of an acute attack: airflow limitation with prolonged expiration, gas trapping and dynamic hyperinflation with intrinsic positive end-expiratory pressure, flattened diaphragm, markedly increased work of breathing, V/Q mismatch causing hypoxaemia, and initially a low carbon dioxide from hyperventilation. A rising or normal carbon dioxide in a distressed asthmatic signals exhaustion and is an ominous sign.
- Why hyperinflation is dangerous in ventilation: rising intrathoracic pressure reduces venous return and raises right ventricular afterload, so hypotension and even arrest can follow positive pressure ventilation or breath stacking; the treatment is to allow a longer expiratory time.
- Aspirin-exacerbated respiratory disease is a pharmacological mechanism rather than an allergy: inhibiting cyclo-oxygenase shunts arachidonic acid down the lipoxygenase route, raising leukotrienes.
Chronic obstructive pulmonary disease and bronchiectasis
- Chronic bronchitis is defined clinically by productive cough; its pathology is mucous gland hypertrophy with an increased Reid index, goblet cell hyperplasia, squamous metaplasia with loss of cilia, airway wall inflammation with neutrophils and CD8 lymphocytes, and small airway fibrosis. The result is obstruction with chronic infection and exacerbations.
- Emphysema is permanent enlargement of airspaces with destruction of alveolar walls and no fibrosis. The mechanism is an imbalance of protease and antiprotease activity: neutrophil elastase and matrix metalloproteinases from cigarette-recruited inflammatory cells overwhelm alpha-1 antitrypsin, which is itself inactivated by oxidants in smoke. Centriacinar emphysema in the upper lobes is typical of smoking; panacinar lower lobe emphysema suggests alpha-1 antitrypsin deficiency, which may coexist with liver disease.
- Physiology: loss of elastic recoil and of radial traction causes early airway collapse on expiration, so gas trapping, hyperinflation and intrinsic positive end-expiratory pressure develop; compliance is increased, diffusing capacity falls, and the diaphragm is flattened and mechanically disadvantaged.
- Consequences: V/Q mismatch with hypoxaemia, eventually chronic hypercapnia with renal bicarbonate retention and a compensated respiratory acidosis, hypoxic pulmonary vasoconstriction leading to pulmonary hypertension and cor pulmonale, secondary polycythaemia, weight loss, and a high risk of pneumothorax from bullae.
- Bronchiectasis is permanent dilatation of bronchi from a cycle of infection, inflammation and destruction of the wall with impaired clearance. Causes: previous severe or recurrent infection (childhood pneumonia, tuberculosis, pertussis), obstruction, impaired clearance (cystic fibrosis, primary ciliary dyskinesia), immune deficiency and allergic bronchopulmonary aspergillosis. It gives copious purulent sputum, haemoptysis (sometimes major, from hypertrophied bronchial arteries) and recurrent infection.
Restrictive and interstitial disease
- Interstitial fibrosis thickens the alveolar wall and destroys architecture, giving stiff lungs, reduced volumes, reduced diffusing capacity and exertional hypoxaemia, with traction bronchiectasis and honeycombing in advanced disease.
- Pattern by cause: idiopathic pulmonary fibrosis (usual interstitial pneumonia, basal and subpleural); occupational disease (asbestosis, basal, with pleural plaques and the separate risk of mesothelioma; silicosis and coal worker disease, upper lobe nodular); hypersensitivity pneumonitis from organic antigens; drug and radiation injury (bleomycin, amiodarone, methotrexate, nitrofurantoin); connective tissue disease and sarcoidosis with non-caseating granulomas and hilar lymphadenopathy.
- Extrapulmonary restriction is important in emergency practice because it is often reversible: obesity and pregnancy, ascites and abdominal distension, large effusion or haemothorax, circumferential burns, kyphoscoliosis, flail chest, pain and splinting, and neuromuscular weakness (Guillain-Barre syndrome, myasthenia, motor neurone disease, high cord lesions).
- Monitoring weakness uses the mechanics rather than oxygenation: a falling vital capacity, weak cough, bulbar dysfunction and rising carbon dioxide precede desaturation, which happens late and suddenly.
Pulmonary embolism and acute lung injury
Source and substrate. Most pulmonary emboli come from deep veins of the legs and pelvis, arising on the basis of Virchow triad: stasis, endothelial injury and hypercoagulability. Other embolic materials have their own pathology: fat (long bone fracture, with confusion, hypoxia and petechiae a day or two later), amniotic fluid (with anaphylactoid collapse and disseminated intravascular coagulation), air, septic emboli, tumour and foreign material.
Consequences follow mechanically and chemically. Occlusion creates alveolar dead space, so ventilation is wasted and the gap between end-tidal and arterial carbon dioxide widens. Mediator release and reflexes cause bronchoconstriction and surfactant loss over hours, giving atelectasis and worsening shunt, so hypoxaemia is often worse than the degree of occlusion suggests. Most patients hyperventilate, so the arterial carbon dioxide is typically low; a rising carbon dioxide indicates massive embolism or exhaustion.
Haemodynamically, pulmonary vascular resistance rises, and because the right ventricle is a thin-walled volume pump it tolerates an acute rise in afterload badly. It dilates, its wall tension and oxygen demand rise while its perfusion pressure falls, and it becomes ischaemic. Dilatation shifts the septum and impairs left ventricular filling, so output falls, coronary perfusion falls further, and the spiral continues to arrest. Infarction of lung tissue is uncommon (the lung has a dual blood supply), which is why most emboli do not cause infarcts and why a pleuritic, haemoptysis-producing peripheral embolus is a particular subgroup. Chronic unresolved embolism causes chronic thromboembolic pulmonary hypertension.
The acute respiratory distress syndrome is the common endpoint of many insults, direct (aspiration, pneumonia, inhalation, contusion, drowning) and indirect (sepsis, pancreatitis, massive transfusion, burns, trauma). The pathology is diffuse alveolar damage in three phases: an exudative phase in the first week with alveolar-capillary barrier injury, neutrophil recruitment, protein-rich permeability oedema and hyaline membranes; a proliferative phase with type II pneumocyte hyperplasia and early fibroblast activity; and in some patients a fibrotic phase. The physiology is non-cardiogenic permeability oedema with surfactant loss, giving stiff lungs, a large shunt and hypoxaemia resistant to oxygen, with heterogeneous aeration, so that the aerated portion is exposed to injurious stretch. That last point explains why ventilation with low tidal volumes limits further damage.
Making the answer flow
- Define obstruction and restriction by mechanism, then the spirometry, then the loop shape; add transfer factor to separate parenchymal from extrapulmonary restriction.
- In asthma, name the three reversible components and then the remodelling changes.
- Explain emphysema as a protease and antiprotease imbalance, and relate the distribution to the cause.
- For pulmonary embolism, go through dead space, then surfactant and shunt, then the right ventricular spiral.
- Give the three phases of diffuse alveolar damage with the timescale.
Where marks are lost
- Being reassured by a normal carbon dioxide in a severe asthma attack.
- Saying emphysema involves fibrosis; the definition excludes it.
- Expecting pulmonary infarction in most emboli, when the dual supply usually prevents it.
- Forgetting that hypoxaemia in embolism is partly due to atelectasis and shunt, not just occlusion.
- Monitoring neuromuscular weakness with oximetry rather than vital capacity.
Where this meets the emergency department
- A normal carbon dioxide in a severely breathless asthmatic is a warning, not reassurance: it means the patient can no longer hyperventilate.
- Follow vital capacity, cough and bulbar function in neuromuscular weakness; oxygen saturation falls late and suddenly.
Viva questions
Answer each one aloud, as you would to an examiner, before you open the model points.
- 1.
How do you distinguish obstructive from restrictive lung disease?
Show answer
- Obstruction: reduced FEV1 to FVC ratio, raised residual volume and total lung capacity, scooped expiratory limb.
- Restriction: reduced total lung capacity and vital capacity with a normal or raised ratio, narrow loop of normal shape.
- Transfer factor separates parenchymal restriction (reduced) from extrapulmonary restriction (preserved).
- A fixed upper airway lesion flattens both limbs of the loop.
- 2.
Describe the pathology of asthma.
Show answer
- Chronic airway inflammation: T helper 2 driven, IgE, mast cell and eosinophil mediated.
- Three reversible components: smooth muscle contraction, mucosal oedema, mucus hypersecretion.
- Microscopy: basement membrane thickening, goblet cell and smooth muscle hyperplasia, eosinophils, Curschmann spirals, Charcot-Leyden crystals.
- Remodelling gives a progressively fixed component.
- 3.
What happens physiologically in a severe asthma attack?
Show answer
- Airflow limitation with prolonged expiration, gas trapping, dynamic hyperinflation and intrinsic positive end-expiratory pressure.
- Flattened diaphragm and greatly increased work of breathing; V/Q mismatch causing hypoxaemia.
- Carbon dioxide initially low; a normal or rising value indicates exhaustion.
- Hyperinflation reduces venous return and raises right ventricular afterload, so positive pressure ventilation can cause hypotension.
- 4.
Explain the pathogenesis of emphysema.
Show answer
- Imbalance between proteases (neutrophil elastase, matrix metalloproteinases) and antiproteases (alpha-1 antitrypsin), with oxidative inactivation of the latter by smoke.
- Destruction of alveolar walls without fibrosis, with loss of elastic recoil and radial traction.
- Centriacinar upper lobe pattern with smoking; panacinar lower lobe pattern with alpha-1 antitrypsin deficiency.
- Consequences: hyperinflation, gas trapping, reduced diffusing capacity, bullae and pneumothorax risk.
- 5.
Why do patients with chronic obstructive pulmonary disease develop cor pulmonale?
Show answer
- Chronic alveolar hypoxia causes sustained hypoxic pulmonary vasoconstriction.
- Vascular remodelling and loss of capillary bed raise pulmonary vascular resistance.
- Hypercapnia, acidosis and polycythaemia add to the load.
- Chronic right ventricular pressure overload leads to hypertrophy then failure with systemic venous congestion.
- 6.
Describe the pathophysiology of pulmonary embolism.
Show answer
- Thrombus from leg or pelvic veins on the basis of Virchow triad; other materials include fat, amniotic fluid, air and septic emboli.
- Alveolar dead space with wasted ventilation and a widened end-tidal to arterial carbon dioxide gap.
- Bronchoconstriction and surfactant loss cause atelectasis and shunt, so hypoxaemia exceeds the degree of occlusion.
- Raised pulmonary vascular resistance causes right ventricular dilatation, ischaemia and impaired left ventricular filling.
- Pulmonary infarction is uncommon because of the dual blood supply.
- 7.
Why does the right ventricle fail so readily in massive pulmonary embolism?
Show answer
- It is a thin-walled volume pump unaccustomed to high afterload.
- Acute dilatation raises wall tension and oxygen demand while systemic hypotension lowers its perfusion pressure, causing ischaemia.
- Septal shift and pericardial constraint impair left ventricular filling, so output falls further.
- Chronic embolism allows hypertrophy, so chronic thromboembolic disease is tolerated better at the same pressure.
- 8.
Describe the pathology of the acute respiratory distress syndrome.
Show answer
- Diffuse alveolar damage from direct causes such as aspiration and pneumonia or indirect causes such as sepsis and pancreatitis.
- Exudative phase in the first week: barrier injury, neutrophil recruitment, protein-rich oedema, hyaline membranes.
- Proliferative phase with type II pneumocyte hyperplasia; fibrotic phase in some patients.
- Physiology: permeability oedema, surfactant loss, stiff lungs, large shunt, hypoxaemia poorly responsive to oxygen.
- Heterogeneous aeration exposes open lung to injurious stretch, the rationale for low tidal volume ventilation.
Practise this week
Week 15 in the other subjects
- Anatomy: Abdominal wall, inguinal region and peritoneum
- Pharmacology: Antipsychotics, antidepressants and lithium
- Physiology: Carbon dioxide transport and control of breathing
Not affiliated with the Australasian College for Emergency Medicine. Notes are a revision aid, not a substitute for the curriculum or for clinical guidelines.